Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemodynamics refers to the physical study and measurement of blood flow and the regulatory mechanisms affecting circulation throughout the cardiovascular system[1][3][7][10]. It encompasses key concepts such as blood pressure (force exerted by blood on vessel walls), blood flow (volume passed per unit time), and vascular resistance (opposition to blood flow within the vessels)[1][4][5][9]. Hemodynamics is not a discrete protein, enzyme, receptor, or molecule, but rather an integrative physiological field applying the principles of fluid dynamics to the movement of blood in the heart and vasculature[1][3][4][5][9][10]. Disturbances in hemodynamics are involved in multiple cardiovascular diseases and conditions, and measurements such as cardiac output, arterial pressure, and vascular resistance are routinely used as biomarkers for diagnosis and management[1][5][9]. Hemodynamic instability (such as seen in shock or heart failure) prompts therapeutic intervention but is not itself a molecular drug target[5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemodynamics of the circulatory system.